IPO registrations (S-1, F-1) · Registrants
Retension Pharmaceuticals, Inc.
- SEC CIK
- 2002988 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2026-09-18, last 2026-10-07; 1 initial registration, 2 amendments
- Outcome
- Final prospectus filed 2026-10-09; declared effective 2026-10-08
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- C/O REDUX THERAPEUTICS, LLC, 902 TURKEY RUN ROAD, Mclean, VA 22101
- EIN
- 93-2592788
- Ticker
- RTSN (Nasdaq)
- EDGAR entity type
- other
Offering terms
- Proposed price range
- $11.00–$13.00 per share (S-1/A filed 2026-10-05)
- Final price
- $12.00 per share, within the range (424B4 filed 2026-10-09, an initial public offering)
- Shares sold
- 3,750,000
- Gross proceeds
- $45,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol RTSN
- Lead underwriters
- Leerink Partners; Guggenheim Securities
- Syndicate
- Oppenheimer; Titan Partners
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form D issuer: Retension Pharmaceuticals, Inc. EXACT (CIK (EXACT))
Filings 6
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2026-09-18 | S-1 | S-1 (registration) | Retension Pharmaceuticals, Inc. | 0001213900-26-101499 ↗ |
| 2026-10-05 | S-1/A | S-1/A (amendment) | Retension Pharmaceuticals, Inc. | 0001213900-26-106636 ↗ |
| 2026-10-07 | S-1/A | S-1/A (amendment) | Retension Pharmaceuticals, Inc. | 0001213900-26-107572 ↗ |
| 2026-10-08 | S-1MEF | S-1MEF (added securities) | Retension Pharmaceuticals, Inc. | 0001213900-26-108143 ↗ |
| 2026-10-08 | EFFECT | EFFECT (declared effective) | Retension Pharmaceuticals, Inc. | 9999999995-26-003189 ↗ |
| 2026-10-09 | 424B4 | 424B4 (final prospectus) | Retension Pharmaceuticals, Inc. | 0001213900-26-108587 ↗ |
Prospectus pages read 3
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-05 | S-1/A | registration statement | $11.00–$13.00 | 3,300,000 | - | Nasdaq RTSN | 4 | primary document; range, shares headline, cover names 4 | document ↗ | |
| 2026-10-07 | S-1/A | registration statement | - | - | 0 | primary document; no terms found | document ↗ | |||
| 2026-10-09 | 424B4 | final prospectus | $12.00 | 3,750,000 | $45,000,000 | Nasdaq RTSN | 4 | primary document; price sentence, shares headline, proceeds table, cover names 4 | document ↗ |
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2025-05-06 | Retension Pharmaceuticals, Inc. | Pharmaceuticals | $20,000,000 | $12,288,567 | 98 | 1 |
| 2023-12-05 | Retension Pharmaceuticals, Inc. | Pharmaceuticals | $11,000,000 | $10,143,750 | 132 | 2 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | Retension Pharmaceuticals, Inc. | VA | Form D private offerings | CIK (EXACT) |
| Patent assignee | Retension Pharmaceuticals, Inc. | VA | Patents (USPTO) | name and state |
| Trademark owner | Retension Pharmaceuticals, Inc. | VA | Trademarks (USPTO) | name and state |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, VA first:
- Osteologix, Inc. VA
- NEW RIVER PHARMACEUTICALS INC VA
- Quoin Pharmaceuticals Ltd. VA
- Aditxt, Inc. VA
- Landos Biopharma, Inc. VA
- MorphoSys AG 2M
- Affimed N.V. 2M
- InflaRx N.V. 2M
- Biofrontera AG 2M
- CURAXIS PHARMACEUTICAL Corp 2Q
In other datasets, the same topic (Health) in VA:
- Nonprofit: ABSTINENCE EDUCATION OF VIRGINIA (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health